Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Seibert

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
The Journal of Antibiotics|April 1, 1992
RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. I. Antibacterial activity in vitroA Bauernfeind, R Jungwirth, E Eberlein, et al.
Drugs|January 1, 1995
Activity of levofloxacin, ofloxacin, D-ofloxacin and ciprofloxacin against systemic and respiratory tract infections in laboratory animalsN Klesel, K H Geweniger, P Koletzki, et al.
Addictive Behaviors|March 6, 2019
Perceived barriers to quitting cigarettes among hospitalized smokers with substance use disorders: A mixed methods studyHasmeena Kathuria, Ryan G Seibert, Vinson Cobb, et al.
The Journal of Antibiotics|November 21, 2001
Pluraflavins, potent antitumor antibiotics from Saccharothrix sp. DSM 12931L Vértesy, F P Barbone, E Cashmen, et al.
Cancer Research|October 1, 1985
Potent antileukemic activity of the novel cytostatic agent avarone and its analogues in vitro and in vivoW E Müller, A Maidhof, R K Zahn, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
The Journal of Antibiotics|April 1, 1992
RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. I. Antibacterial activity in vitroA Bauernfeind, R Jungwirth, E Eberlein, et al.
Drugs|January 1, 1995
Activity of levofloxacin, ofloxacin, D-ofloxacin and ciprofloxacin against systemic and respiratory tract infections in laboratory animalsN Klesel, K H Geweniger, P Koletzki, et al.
Addictive Behaviors|March 6, 2019
Perceived barriers to quitting cigarettes among hospitalized smokers with substance use disorders: A mixed methods studyHasmeena Kathuria, Ryan G Seibert, Vinson Cobb, et al.
The Journal of Antibiotics|November 21, 2001
Pluraflavins, potent antitumor antibiotics from Saccharothrix sp. DSM 12931L Vértesy, F P Barbone, E Cashmen, et al.
Cancer Research|October 1, 1985
Potent antileukemic activity of the novel cytostatic agent avarone and its analogues in vitro and in vivoW E Müller, A Maidhof, R K Zahn, et al.
Pageof 9